Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-05-02 00:22:30 UTC |
---|
Updated at | 2024-09-03 04:20:38 UTC |
---|
NP-MRD ID | NP0332905 |
---|
Natural Product DOI | https://doi.org/10.57994/2186 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | CCB |
---|
Description | CCB was first documented in 2024 (PMID: 39305202). Based on a literature review a significant number of articles have been published on CCB (PMID: 39284281) (PMID: 39277872) (PMID: 39262859) (PMID: 39253317) (PMID: 39241582) (PMID: 39238719). |
---|
Structure | [H][C@]12OC3=C(C(O)=CC(CCCCC)=C3)[C@@]1([H])[C@@]1([H])CC[C@]2(C)OC1(C)C InChI=1S/C21H30O3/c1-5-6-7-8-13-11-15(22)18-16(12-13)23-19-17(18)14-9-10-21(19,4)24-20(14,2)3/h11-12,14,17,19,22H,5-10H2,1-4H3/t14-,17-,19+,21+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H30O3 |
---|
Average Mass | 330.4680 Da |
---|
Monoisotopic Mass | 330.21949 Da |
---|
IUPAC Name | (1R,2R,10S,11S)-11,13,13-trimethyl-6-pentyl-9,12-dioxatetracyclo[9.2.2.0^{2,10}.0^{3,8}]pentadeca-3(8),4,6-trien-4-ol |
---|
Traditional Name | (1R,2R,10S,11S)-11,13,13-trimethyl-6-pentyl-9,12-dioxatetracyclo[9.2.2.0^{2,10}.0^{3,8}]pentadeca-3(8),4,6-trien-4-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@]12OC3=C(C(O)=CC(CCCCC)=C3)[C@@]1([H])[C@@]1([H])CC[C@]2(C)OC1(C)C |
---|
InChI Identifier | InChI=1S/C21H30O3/c1-5-6-7-8-13-11-15(22)18-16(12-13)23-19-17(18)14-9-10-21(19,4)24-20(14,2)3/h11-12,14,17,19,22H,5-10H2,1-4H3/t14-,17-,19+,21+/m1/s1 |
---|
InChI Key | RFLHMZVKMQKUEC-DYZHCLJRSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
HSQC NMR | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3CN, experimental) | alessio.porta@unipv.it | University of Pavia | Alessio Porta | 2024-05-02 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, CD3CN, experimental) | alessio.porta@unipv.it | University of Pavia | Alessio Porta | 2024-05-02 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3CN, experimental) | alessio.porta@unipv.it | University of Pavia | Alessio Porta | 2024-05-02 | View Spectrum | 1D_DEPT NMR | 13C NMR Spectrum (1D, 101 MHz, CD3CN, experimental) | alessio.porta@unipv.it | University of Pavia | Alessio Porta | 2024-05-02 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CD3CN, experimental) | alessio.porta@unipv.it | University of Pavia | Alessio Porta | 2024-05-02 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
sp. | | |
|
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as furopyrans. These are organic polycyclic compounds containing a furan ring fused to a pyran ring. Furan is a five-membered aromatic ring with four carbon atoms and one oxygen atom. Pyran a six-membered heterocyclic, non-aromatic ring, made up of five carbon atoms and one oxygen atom and containing two double bonds. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Furopyrans |
---|
Sub Class | Not Available |
---|
Direct Parent | Furopyrans |
---|
Alternative Parents | |
---|
Substituents | - Coumaran
- Furopyran
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Benzenoid
- Pyran
- Oxane
- Furan
- Dihydrofuran
- Oxacycle
- Ether
- Dialkyl ether
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Isbister GK, Jenkins S, Harris K, Downes MA, Isoardi KZ: Calcium channel blocker overdose: Not all the same toxicity. Br J Clin Pharmacol. 2024 Sep 21. doi: 10.1111/bcp.16258. [PubMed:39305202 ]
- Subramanian R, Roebuck A, Joshi H, Drouin M: Predictors of Mortality in Adults With Calcium Channel Blocker Toxicity Receiving Extra Corporeal Membrane Oxygenation Support: An Extracorporeal Life Support Organization Registry Analysis. ASAIO J. 2024 Sep 3. doi: 10.1097/MAT.0000000000002307. [PubMed:39284281 ]
- Mori M, Kawakami H, Tobita R, Arai T, Satsuma A, Tsuboi R, Okubo Y: Psoriasiform drug eruption: A case series with a review of the literature. Exp Dermatol. 2024 Sep;33(9):e15174. doi: 10.1111/exd.15174. [PubMed:39277872 ]
- Abdullahi S, Haris H, Zarkasi KZ, Ghazali AH: Alleviation of Cadmium Stress in Rice Seedlings Inoculated with Enterobacter tabaci 4M9 (CCB-MBL 5004). Trop Life Sci Res. 2024 Mar;35(1):107-121. doi: 10.21315/tlsr2024.35.1.6. Epub 2024 Mar 30. [PubMed:39262859 ]
- Varatharajan S, Bohra GK, Bhatia PK, Khichar S, Meena M, Palanisamy N, Gaur A, Garg MK: Outcome of COVID-19 infection in patients on antihypertensives: A cross-sectional study. World J Crit Care Med. 2024 Sep 9;13(3):96882. doi: 10.5492/wjccm.v13.i3.96882. eCollection 2024 Sep 9. [PubMed:39253317 ]
- Wang X, Lu Y, Li M, Xia X, Jin C, Ding K, Chen D: Structural characterization and Bacteroides proliferation promotion activity of a novel homogeneous arabinoglucuronoxylan from Commelina communis L. Bioorg Chem. 2024 Sep 2;153:107790. doi: 10.1016/j.bioorg.2024.107790. [PubMed:39241582 ]
- Lodha S, Loriaux D, Faulkner AL, Pearson K, Shah S: Single-Dose Calcium Channel Blocker Toxicity in a Patient With Severe Liver Disease. Cureus. 2024 Aug 6;16(8):e66308. doi: 10.7759/cureus.66308. eCollection 2024 Aug. [PubMed:39238719 ]
- Zappala T, Pottegard A, Huber CA, Reinau D, Meier CR, Spoendlin J: Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data. Pharmacoepidemiol Drug Saf. 2024 Sep;33(9):e70005. doi: 10.1002/pds.70005. [PubMed:39223977 ]
- Atici A, Sahin I, Dogan O, Barman HA, Kup A, Celik M, Demirkiran A, Yilmaz Y, Ozcan FB, Cevik E, Orta H, Yilmaz M, Soysal AU, Yumuk MT, Yavuz ST, Ozturk F, Karaduman M, Yilmaz I, Caliskan M: Can the efficacy of a medical treatment be predicted based on the type of idiopathic premature ventricular contraction? J Electrocardiol. 2024 Sep-Oct;86:153782. doi: 10.1016/j.jelectrocard.2024.153782. Epub 2024 Aug 22. [PubMed:39216311 ]
- de Almeida Roque A, Zablocki da Luz J, Filipak Neto F, Barjhoux I, Rioult D, de Oliveira Ribeiro CA: Low concentrations of complex mixtures of pesticides and metabolites are toxic to common Carp brain cells (Cyprinus carpio carpio). Drug Chem Toxicol. 2024 Aug 29:1-11. doi: 10.1080/01480545.2024.2397432. [PubMed:39210515 ]
- Capucciati A, Casali E, Bini A, Doria F, Merli D, Porta A: Easy and Accessible Synthesis of Cannabinoids from CBD. J Nat Prod. 2024 Apr 26;87(4):869-875. doi: 10.1021/acs.jnatprod.3c01117. Epub 2024 Mar 1. [PubMed:38427968 ]
|
---|